Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck (scientific article published on January 2004)

Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1

Q24685938

Cancer statistics, 2002

Q28216788

Expression cloning and cDNA sequencing of the Na+/glucose co-transporter

Q28306556

Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1).

Q31808201

Cloning and expression of a hepatic microsomal glucose transport protein. Comparison with liver plasma-membrane glucose-transport protein GLUT 2

Q33203855

Analysis of kinetic data in transport studies: new insights from kinetic studies of Na(+)-D-glucose cotransport in human intestinal brush-border membrane vesicles using a fast sampling, rapid filtration apparatus

Q33379597

Overview of glucose regulation

Q34245809

Value of whole-body FDG PET in management of lung cancer

Q35105451

The glucose transporter family: structure, function and tissue-specific expression.

Q40780047

Glucose transporters in the transepithelial transport of glucose

Q41185877

Characterization of an electrogenic sodium/glucose cotransporter in a human colon epithelial cell line

Q41352353

Regulation of the ovine intestinal Na+/glucose co-transporter (SGLT1) is dissociated from mRNA abundance

Q42035899

SGLT gene expression in primary lung cancers and their metastatic lesions

Q43709713

Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings.

Q44403037

Global cancer statistics

Q44583516

Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck

Q71218245

Antihyperglycemic effect of T-1095 via inhibition of renal Na+-glucose cotransporters in streptozotocin-induced diabetic rats

Q73364345

Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats

Q74299782

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

28-35

P577

publication date

2004-01-01

P1433

published in

Oral Oncology

Q7099367

P1476

title

Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck

P478

volume

Reverse relations

cites work (P2860)

Q35084141	Analysis of metabolism of 6FDG: a PET glucose transport tracer
Q39537494	Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma
Q38554153	EGFR kinase-dependent and kinase-independent roles in clear cell renal cell carcinoma
Q39270164	EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas.
Q36881828	Exogenous expression of human SGLT1 exhibits aggregations in sodium dodecyl sulfate polyacrylamide gel electrophoresis
Q34657372	Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
Q33862612	HDAC inhibition decreases the expression of EGFR in colorectal cancer cells
Q64287338	Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications
Q37095176	Ionizing radiation, ion transports, and radioresistance of cancer cells
Q38406543	Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma
Q24309274	Survival of cancer cells is maintained by EGFR independent of its kinase activity
Q38126109	The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors
Q33674221	The role of dysregulated glucose metabolism in epithelial ovarian cancer

P356	DOI	10.1016/S1368-8375(03)00129-5
P698	PubMed publication ID	14662412